Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell-cell adhesion	SDK2 NRCAM PKD1L1 AKNA LAMA3 FNDC3A ADGRV1 DSCAML1 SLC4A1 PTK7 BMP4 CD4 HMCN2 PTPRD HMCN1 NF2 PTPRS PIK3CG PDE5A CDH2 CDH4 SDK1 CNTN2 CDH17 GP1BA	1.65e-09	1077	118	25	GO:0098609
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	SDK2 NRCAM DSCAML1 PTK7 HMCN2 HMCN1 CDH2 CDH4 SDK1 CNTN2 CDH17	1.04e-08	187	118	11	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	SDK2 NRCAM DSCAML1 PTK7 HMCN2 PTPRD HMCN1 PTPRS CDH2 CDH4 SDK1 CNTN2 CDH17	2.95e-08	313	118	13	GO:0098742
GeneOntologyBiologicalProcess	mesenchymal cell migration	SEMA6B ERBB4 FN1 BMP4 SEMA6D CDH2	1.76e-06	64	118	6	GO:0090497
GeneOntologyBiologicalProcess	stem cell development	SEMA6B ERBB4 FN1 BMP4 SETD2 SEMA6D CDH2	1.85e-06	101	118	7	GO:0048864
GeneOntologyBiologicalProcess	cell morphogenesis	SEMA6B FN1 NRCAM STXBP5 LAMA3 ATP10A DSCAML1 PTK7 HMCN2 PTPRD SEMA6D NF2 PTPRS PTPRQ DMD CDH2 CDH4 CNTN2 CDH17 GP1BA BRWD1	3.79e-06	1194	118	21	GO:0000902
GeneOntologyBiologicalProcess	neural crest cell development	SEMA6B ERBB4 FN1 BMP4 SEMA6D CDH2	1.22e-05	89	118	6	GO:0014032
GeneOntologyBiologicalProcess	axonogenesis	SEMA6B FN1 NRCAM STXBP5 LAMA3 DSCAML1 PTK7 HMCN2 SEMA6D PTPRS CDH2 CDH4 CNTN2	2.18e-05	566	118	13	GO:0007409
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	SEMA6B FN1 NRCAM STXBP5 LAMA3 DSCAML1 PTK7 HMCN2 PTPRD SEMA6D PTPRS PTPRQ CDH2 CDH4 CNTN2	2.42e-05	748	118	15	GO:0048667
GeneOntologyBiologicalProcess	neural crest cell migration	SEMA6B ERBB4 FN1 BMP4 SEMA6D	2.81e-05	62	118	5	GO:0001755
GeneOntologyBiologicalProcess	neural crest cell differentiation	SEMA6B ERBB4 FN1 BMP4 SEMA6D CDH2	2.97e-05	104	118	6	GO:0014033
GeneOntologyBiologicalProcess	animal organ morphogenesis	SP3 ERBB4 SDK2 LAMA3 DSCAML1 CASZ1 TNFRSF11B PTK7 PHEX BMP4 SETD2 NF2 PTPRQ TIMELESS USH2A CDH2 SDK1 ALPK2 MYBPC3 WDR72	3.27e-05	1269	118	20	GO:0009887
GeneOntologyBiologicalProcess	axon guidance	SEMA6B NRCAM LAMA3 DSCAML1 PTK7 HMCN2 SEMA6D CDH4 CNTN2	3.89e-05	285	118	9	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	SEMA6B NRCAM LAMA3 DSCAML1 PTK7 HMCN2 SEMA6D CDH4 CNTN2	3.99e-05	286	118	9	GO:0097485
GeneOntologyBiologicalProcess	neuron projection morphogenesis	SEMA6B FN1 NRCAM STXBP5 LAMA3 DSCAML1 PTK7 HMCN2 PTPRD SEMA6D PTPRS DMD CDH2 CDH4 CNTN2	5.36e-05	802	118	15	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	SEMA6B FN1 NRCAM STXBP5 LAMA3 DSCAML1 PTK7 HMCN2 PTPRD SEMA6D PTPRS DMD CDH2 CDH4 CNTN2	6.79e-05	819	118	15	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	SEMA6B FN1 NRCAM STXBP5 LAMA3 DSCAML1 PTK7 HMCN2 PTPRD SEMA6D PTPRS DMD CDH2 CDH4 CNTN2	7.47e-05	826	118	15	GO:0048858
GeneOntologyBiologicalProcess	axon development	SEMA6B FN1 NRCAM STXBP5 LAMA3 DSCAML1 PTK7 HMCN2 SEMA6D PTPRS CDH2 CDH4 CNTN2	7.93e-05	642	118	13	GO:0061564
GeneOntologyBiologicalProcess	cell junction organization	ERBB4 SDK2 FN1 NRCAM LAMA3 PTK7 HMCN2 PTPRD NF2 PTPRS CDH2 CDH4 SDK1 CNTN2 SHISA6 CDH17	1.36e-04	974	118	16	GO:0034330
GeneOntologyBiologicalProcess	dendrite self-avoidance	NRCAM DSCAML1 CNTN2	1.40e-04	18	118	3	GO:0070593
GeneOntologyBiologicalProcess	cell recognition	NRCAM MYO18A DSCAML1 OPCML VCAN PCSK4 CNTN2	1.45e-04	198	118	7	GO:0008037
GeneOntologyBiologicalProcess	regulation of blastocyst development	TTLL4 TTLL1	1.93e-04	4	118	2	GO:0120222
GeneOntologyBiologicalProcess	neuron development	SEMA6B FN1 NRCAM STXBP5 LAMA3 ADGRV1 DSCAML1 OPCML PTK7 BMP4 HMCN2 PTPRD SEMA6D PTPRS PTPRQ DMD CDH2 CDH4 SDK1 CNTN2	2.29e-04	1463	118	20	GO:0048666
GeneOntologyBiologicalProcess	maintenance of animal organ identity	ADGRV1 USH2A	3.21e-04	5	118	2	GO:0048496
GeneOntologyBiologicalProcess	regulation of axon extension	FN1 NRCAM SEMA6D PTPRS CDH4	3.30e-04	104	118	5	GO:0030516
GeneOntologyBiologicalProcess	neuron recognition	NRCAM DSCAML1 OPCML CNTN2	3.63e-04	59	118	4	GO:0008038
GeneOntologyBiologicalProcess	neuron projection development	SEMA6B FN1 NRCAM STXBP5 LAMA3 ADGRV1 DSCAML1 PTK7 BMP4 HMCN2 PTPRD SEMA6D PTPRS DMD CDH2 CDH4 SDK1 CNTN2	3.65e-04	1285	118	18	GO:0031175
GeneOntologyBiologicalProcess	brain development	SEMA6B ERBB4 NRCAM AKNA DSCAML1 TTBK2 BMP4 SETD2 SEMA6D NF2 PTPRS TTLL1 CDH2 CNTN2	3.98e-04	859	118	14	GO:0007420
GeneOntologyBiologicalProcess	cell junction assembly	ERBB4 SDK2 FN1 NRCAM LAMA3 PTPRD PTPRS CDH2 CDH4 SDK1 CDH17	4.26e-04	569	118	11	GO:0034329
GeneOntologyBiologicalProcess	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	PTPRD HMCN1 CDH2 CDH4	4.67e-04	63	118	4	GO:0007157
GeneOntologyBiologicalProcess	regulation of postsynaptic density organization	PTPRD PTPRS CDH2	4.83e-04	27	118	3	GO:1905874
GeneOntologyBiologicalProcess	forebrain development	SEMA6B ERBB4 AKNA TTBK2 BMP4 SETD2 NF2 PTPRS CDH2 CNTN2	5.08e-04	489	118	10	GO:0030900
GeneOntologyCellularComponent	USH2 complex	ADGRV1 USH2A	1.88e-04	4	118	2	GO:1990696
GeneOntologyCellularComponent	myosin filament	MYO18A MYOM2 MYBPC3	3.68e-04	25	118	3	GO:0032982
GeneOntologyCellularComponent	cleavage furrow	HTR3A HMCN2 HMCN1 NF2	3.93e-04	61	118	4	GO:0032154
GeneOntologyCellularComponent	stereocilia ankle link	ADGRV1 USH2A	4.67e-04	6	118	2	GO:0002141
GeneOntologyCellularComponent	stereocilia ankle link complex	ADGRV1 USH2A	4.67e-04	6	118	2	GO:0002142
GeneOntologyCellularComponent	stereocilium membrane	ADGRV1 USH2A	4.67e-04	6	118	2	GO:0060171
GeneOntologyCellularComponent	periciliary membrane compartment	ADGRV1 USH2A	4.67e-04	6	118	2	GO:1990075
GeneOntologyCellularComponent	cell surface	NRCAM MYO18A MUC16 ADGRV1 DSCAML1 SLC4A1 CD4 SEMA6D PEBP1 VCAN DMD ADGRE1 CDH2 CNTN2 CDH17 GP1BA	5.12e-04	1111	118	16	GO:0009986
GeneOntologyCellularComponent	basement membrane	FN1 LAMA3 HMCN2 HMCN1 USH2A	6.45e-04	122	118	5	GO:0005604
GeneOntologyCellularComponent	catenin complex	CDH2 CDH4 CDH17	7.72e-04	32	118	3	GO:0016342
GeneOntologyCellularComponent	stereocilia coupling link	ADGRV1 USH2A	8.65e-04	8	118	2	GO:0002139
GeneOntologyCellularComponent	cell division site	HTR3A HMCN2 HMCN1 NF2	1.10e-03	80	118	4	GO:0032153
GeneOntologyCellularComponent	adherens junction	LAMA3 HMCN1 NF2 CDH2 CDH4 CDH17	1.30e-03	212	118	6	GO:0005912
GeneOntologyCellularComponent	receptor complex	ERBB4 HTR3A STXBP5 INSRR ADGRV1 TNFRSF11B CD4 PTPRQ SHISA6 GP1BA	1.69e-03	581	118	10	GO:0043235
GeneOntologyCellularComponent	synaptic membrane	ERBB4 HTR3A NRCAM STXBP5 PTPRD PTPRS DMD CDH2 CNTN2 SHISA6	1.73e-03	583	118	10	GO:0097060
GeneOntologyCellularComponent	postsynaptic membrane	ERBB4 HTR3A NRCAM PTPRS DMD CDH2 CNTN2 SHISA6	2.13e-03	405	118	8	GO:0045211
Domain	Ig_I-set	SDK2 NRCAM DSCAML1 OPCML PTK7 HMCN2 PTPRD HMCN1 PTPRS MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	7.90e-12	190	112	14	IPR013098
Domain	I-set	SDK2 NRCAM DSCAML1 OPCML PTK7 HMCN2 PTPRD HMCN1 PTPRS MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	7.90e-12	190	112	14	PF07679
Domain	IGc2	SDK2 NRCAM DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	1.07e-11	235	112	15	SM00408
Domain	Ig_sub2	SDK2 NRCAM DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	1.07e-11	235	112	15	IPR003598
Domain	fn3	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 PTPRD PTPRS MYOM2 USH2A SDK1 CNTN2 MYBPC3	1.57e-11	162	112	13	PF00041
Domain	FN3	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 PTPRD PTPRS MYOM2 USH2A SDK1 CNTN2 MYBPC3	8.36e-11	185	112	13	SM00060
Domain	FN3	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 PTPRD PTPRS MYOM2 USH2A SDK1 CNTN2 MYBPC3	2.08e-10	199	112	13	PS50853
Domain	FN3_dom	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 PTPRD PTPRS MYOM2 USH2A SDK1 CNTN2 MYBPC3	3.81e-10	209	112	13	IPR003961
Domain	Ig-like_fold	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS VCAN PRKAB2 MYOM2 USH2A SDK1 CNTN2 ALPK2 MYBPC3	1.12e-09	706	112	21	IPR013783
Domain	IG	SDK2 NRCAM DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS VCAN MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	4.41e-09	421	112	16	SM00409
Domain	Ig_sub	SDK2 NRCAM DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS VCAN MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	4.41e-09	421	112	16	IPR003599
Domain	-	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 OPCML PTK7 CD4 PTPRD HMCN1 PTPRS VCAN MYOM2 USH2A SDK1 CNTN2 ALPK2 MYBPC3	1.41e-08	663	112	19	2.60.40.10
Domain	IG_LIKE	SDK2 NRCAM DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS VCAN MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	3.81e-08	491	112	16	PS50835
Domain	Ig-like_dom	SDK2 NRCAM DSCAML1 OPCML PTK7 CD4 HMCN2 PTPRD HMCN1 PTPRS VCAN MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	5.32e-08	503	112	16	IPR007110
Domain	ig	SDK2 NRCAM DSCAML1 OPCML CD4 PTPRD HMCN1 PTPRS CNTN2	2.15e-06	190	112	9	PF00047
Domain	Immunoglobulin	SDK2 NRCAM DSCAML1 OPCML CD4 PTPRD HMCN1 PTPRS CNTN2	2.15e-06	190	112	9	IPR013151
Domain	Growth_fac_rcpt_	ERBB4 INSRR LAMA3 HMCN2 HMCN1 ELAPOR1 ADGRE1 PCSK4	4.51e-06	156	112	8	IPR009030
Domain	GPS	PKD1L1 ADGRV1 ADGRG4 ADGRE1	6.22e-05	36	112	4	PS50221
Domain	GPS	PKD1L1 ADGRV1 ADGRG4 ADGRE1	6.95e-05	37	112	4	IPR000203
Domain	Furin_repeat	ERBB4 INSRR PCSK4	1.60e-04	18	112	3	IPR006212
Domain	FU	ERBB4 INSRR PCSK4	1.60e-04	18	112	3	SM00261
Domain	G2F	HMCN2 HMCN1	2.12e-04	4	112	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	2.12e-04	4	112	2	PS50993
Domain	GFP	HMCN2 HMCN1	2.12e-04	4	112	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	2.12e-04	4	112	2	IPR006605
Domain	Recep_L_domain	ERBB4 INSRR	7.34e-04	7	112	2	PF01030
Domain	Cadherin_pro	CDH2 CDH4	7.34e-04	7	112	2	PF08758
Domain	Furin-like	ERBB4 INSRR	7.34e-04	7	112	2	PF00757
Domain	Rcpt_L-dom	ERBB4 INSRR	7.34e-04	7	112	2	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB4 INSRR	7.34e-04	7	112	2	IPR006211
Domain	-	ERBB4 INSRR	7.34e-04	7	112	2	3.80.20.20
Domain	EGF_1	FN1 LAMA3 HMCN2 HMCN1 VCAN ADGRE1 USH2A	8.74e-04	255	112	7	PS00022
Domain	Cadherin_pro	CDH2 CDH4	9.75e-04	8	112	2	SM01055
Domain	Cadherin_pro_dom	CDH2 CDH4	9.75e-04	8	112	2	IPR014868
Domain	GPS	ADGRV1 ADGRG4 ADGRE1	1.10e-03	34	112	3	SM00303
Domain	GPS	ADGRV1 ADGRG4 ADGRE1	1.19e-03	35	112	3	PF01825
Domain	Kinase-like_dom	ERBB4 ADCK5 INSRR STYK1 PTK7 TTBK2 PIK3CG BUB1B DMD ALPK2	1.56e-03	542	112	10	IPR011009
Domain	RECEPTOR_TYR_KIN_II	INSRR PTK7	2.26e-03	12	112	2	PS00239
Domain	-	LAMA3 ADGRV1 ADGRG4 USH2A	2.57e-03	95	112	4	2.60.120.200
Domain	Kelch_2	RABEPK KLHDC4	2.66e-03	13	112	2	IPR011498
Domain	TTL	TTLL4 TTLL1	2.66e-03	13	112	2	PS51221
Domain	TTL/TTLL_fam	TTLL4 TTLL1	2.66e-03	13	112	2	IPR004344
Domain	Kelch_2	RABEPK KLHDC4	2.66e-03	13	112	2	PF07646
Domain	TTL	TTLL4 TTLL1	2.66e-03	13	112	2	PF03133
Domain	PROTEIN_KINASE_TYR	ERBB4 INSRR STYK1 PTK7	2.77e-03	97	112	4	PS00109
Domain	EGF_Ca-bd_CS	HMCN2 HMCN1 VCAN ADGRE1	2.77e-03	97	112	4	IPR018097
Domain	Tyr_kinase_AS	ERBB4 INSRR STYK1 PTK7	2.77e-03	97	112	4	IPR008266
Domain	EGF_CA	HMCN2 HMCN1 VCAN ADGRE1	2.98e-03	99	112	4	PS01187
Domain	ASX_HYDROXYL	HMCN2 HMCN1 VCAN ADGRE1	3.09e-03	100	112	4	PS00010
Domain	IBR	RNF19B RBCK1	3.09e-03	14	112	2	PF01485
Domain	7tm_2	ADGRV1 ADGRG4 ADGRE1	3.35e-03	50	112	3	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRV1 ADGRG4 ADGRE1	3.35e-03	50	112	3	PS00650
Domain	IBR_dom	RNF19B RBCK1	3.56e-03	15	112	2	IPR002867
Domain	EGF-type_Asp/Asn_hydroxyl_site	HMCN2 HMCN1 VCAN ADGRE1	3.81e-03	106	112	4	IPR000152
Domain	-	SEMA6B STXBP5 WDR43 SEMA6D ELP2 BRWD1 WDR72	3.95e-03	333	112	7	2.130.10.10
Domain	Laminin_N	LAMA3 USH2A	4.05e-03	16	112	2	IPR008211
Domain	LamNT	LAMA3 USH2A	4.05e-03	16	112	2	SM00136
Domain	LAMININ_NTER	LAMA3 USH2A	4.05e-03	16	112	2	PS51117
Domain	Laminin_N	LAMA3 USH2A	4.05e-03	16	112	2	PF00055
Domain	WD40/YVTN_repeat-like_dom	SEMA6B STXBP5 WDR43 SEMA6D ELP2 BRWD1 WDR72	4.08e-03	335	112	7	IPR015943
Domain	EGF-like_CS	FN1 LAMA3 HMCN2 HMCN1 VCAN ADGRE1	4.90e-03	261	112	6	IPR013032
Domain	GPCR_2_secretin-like	ADGRV1 ADGRG4 ADGRE1	5.60e-03	60	112	3	IPR000832
Domain	GPCR_2-like	ADGRV1 ADGRG4 ADGRE1	5.60e-03	60	112	3	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRV1 ADGRG4 ADGRE1	5.87e-03	61	112	3	PS50261
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	SDK2 CDH2 CDH4 SDK1 CDH17	1.05e-05	48	86	5	MM15069
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	SDK2 LAMA3 CDH2 CDH4 SDK1 CDH17	7.87e-05	117	86	6	M19248
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	SDK2 CDH2 CDH4 SDK1 CDH17	8.15e-05	73	86	5	MM15126
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	NRCAM CD4 VCAN CDH2 CDH4 CNTN2	1.60e-04	133	86	6	M16476
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	SEMA6B SDK2 DSCAML1 SEMA6D SDK1 CNTN2	2.53e-08	52	119	6	26633812
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	NRCAM DSCAML1 OPCML PTK7 PTPRD HMCN1 PTPRS CNTN2	9.42e-08	162	119	8	25826454
Pubmed	The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development.	ERBB4 FN1 BMP4 CDH2	1.31e-06	24	119	4	10021345
Pubmed	Distinct adhesive behaviors of neurons and neural precursor cells during regional differentiation in the mammalian forebrain.	FN1 CDH2 CNTN2	2.16e-06	8	119	3	7750641
Pubmed	Developmental gene expression profiling along the tonotopic axis of the mouse cochlea.	NRCAM BMP4 PTPRQ CDH4	2.50e-06	28	119	4	22808246
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SDK2 HIVEP1 PKD1L1 YTHDC2 ICE1 ATP10A HMCN2 SPEN DNAH9	4.49e-06	361	119	9	26167880
Pubmed	Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice.	SEMA6B BMP4 SEMA6D VCAN	6.28e-06	35	119	4	28172500
Pubmed	A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain.	PTPRD PTPRS PTPRQ	6.32e-06	11	119	3	7832766
Pubmed	Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice.	FN1 BMP4 CD4 CDH2	7.89e-06	37	119	4	34323105
Pubmed	Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin.	FN1 LAMA3 CD4 ADGRE1	8.79e-06	38	119	4	27653694
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	ERBB4 INSRR STYK1 PTK7	1.08e-05	40	119	4	30898150
Pubmed	Serum Antibodies to N-Glycolylneuraminic Acid Are Elevated in Duchenne Muscular Dystrophy and Correlate with Increased Disease Pathology in Cmah-/-mdx Mice.	DMD CMAHP	1.16e-05	2	119	2	34294193
Pubmed	Molecular cloning of mouse pancreatic islet R-cadherin: differential expression in endocrine and exocrine tissue.	CDH2 CDH4	1.16e-05	2	119	2	8247017
Pubmed	A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.	DMD CMAHP	1.16e-05	2	119	2	20668298
Pubmed	Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.	NPC1 SMPD1	1.16e-05	2	119	2	7670466
Pubmed	Niemann-Pick disease.	NPC1 SMPD1	1.16e-05	2	119	2	10608504
Pubmed	Genetic reduction of the extracellular matrix protein versican attenuates inflammatory cell infiltration and improves contractile function in dystrophic mdx diaphragm muscles.	VCAN DMD	1.16e-05	2	119	2	32632164
Pubmed	Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy.	SDK2 SDK1	1.16e-05	2	119	2	15213259
Pubmed	Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.	DMD CMAHP	1.16e-05	2	119	2	29912990
Pubmed	Renal Na(+)-phosphate cotransporter gene expression in X-linked Hyp and Gy mice.	PHEX DMD	1.16e-05	2	119	2	8691720
Pubmed	A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse.	FN1 VCAN	1.16e-05	2	119	2	9188753
Pubmed	Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death Against Human Non-Small Cell Lung Cancers.	BUB1B PDE5A	1.16e-05	2	119	2	32764382
Pubmed	Definition of the critical domains required for homophilic targeting of mouse sidekick molecules.	SDK2 SDK1	1.16e-05	2	119	2	15703275
Pubmed	Architecture of cell-cell adhesion mediated by sidekicks.	SDK2 SDK1	1.16e-05	2	119	2	30150416
Pubmed	Histone methyltransferase SETD2 is required for meiotic maturation in mouse oocyte.	SETD2 BUB1B	1.16e-05	2	119	2	30078214
Pubmed	Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.	PDE5A DMD	1.16e-05	2	119	2	22653783
Pubmed	N-cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTPsigma) and participates in PTPsigma-mediated inhibition of axon growth.	PTPRS CDH2	1.16e-05	2	119	2	17060446
Pubmed	Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype.	ADGRV1 USH2A	1.16e-05	2	119	2	15671307
Pubmed	Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush.	ADGRV1 USH2A	1.16e-05	2	119	2	34638692
Pubmed	The Relationship between Cadherin Polymorphisms and the Risk of Delayed Encephalopathy after Acute Carbon Monoxide Poisoning in the Chinese Han Population.	CDH2 CDH17	1.16e-05	2	119	2	35140817
Pubmed	Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations.	NPC1 SMPD1	1.16e-05	2	119	2	26790753
Pubmed	Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation.	ADGRV1 USH2A	1.16e-05	2	119	2	28653555
Pubmed	Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression.	FN1 VCAN	1.16e-05	2	119	2	23201264
Pubmed	Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function.	DMD MYBPC3	1.16e-05	2	119	2	23936073
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	1.16e-05	2	119	2	32035013
Pubmed	The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling.	NPC1 SMPD1	1.16e-05	2	119	2	8181053
Pubmed	Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice.	NPC1 SMPD1	1.16e-05	2	119	2	9565090
Pubmed	Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.	DMD CMAHP	1.16e-05	2	119	2	30281092
Pubmed	Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ.	ADGRV1 PTPRQ	1.16e-05	2	119	2	22357859
Pubmed	Mouse models of Niemann-Pick disease: mutation analysis and chromosomal mapping rule out the type A and B forms.	NPC1 SMPD1	1.16e-05	2	119	2	8288255
Pubmed	Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease).	NPC1 SMPD1	1.16e-05	2	119	2	7600574
Pubmed	Functional cis-heterodimers of N- and R-cadherins.	CDH2 CDH4	1.16e-05	2	119	2	10662782
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	1.16e-05	2	119	2	9566880
Pubmed	Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina.	SDK2 SDK1	1.16e-05	2	119	2	12230981
Pubmed	Nr-CAM and TAG-1 are expressed in distinct populations of developing precerebellar and cerebellar neurons.	NRCAM CNTN2	1.16e-05	2	119	2	12182881
Pubmed	SP3-induced Timeless transcription contributes to cell growth of lung adenocarcinoma cells.	SP3 TIMELESS	1.16e-05	2	119	2	38354174
Pubmed	Molecular basis of sidekick-mediated cell-cell adhesion and specificity.	SDK2 SDK1	1.16e-05	2	119	2	27644106
Pubmed	DSCAM promotes axon fasciculation and growth in the developing optic pathway.	NRCAM DSCAML1 CNTN2	1.38e-05	14	119	3	28137836
Pubmed	Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.	FN1 VCAN CDH2	1.38e-05	14	119	3	27687499
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	SDK2 SEMA6D CDH2 CDH4 SDK1	1.58e-05	91	119	5	28558017
Pubmed	Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin.	FN1 LAMA3 ADGRE1	1.72e-05	15	119	3	34721382
Pubmed	Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing.	SEMA6B NRCAM SEMA6D	2.12e-05	16	119	3	22632726
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	ADGRV1 PTPRQ USH2A	2.12e-05	16	119	3	17567809
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NPC1 SEMA6B CRYBG2 MAN2B1 AKNA ICE1 TTYH3 CASZ1 BMP4 ARAP3 NF2 PTPRS TTLL4 SPEN	2.62e-05	1105	119	14	35748872
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	FN1 BUB1B TOMM34 ELP2 TIMELESS	3.31e-05	106	119	5	31024071
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	3.47e-05	3	119	2	12388743
Pubmed	Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase.	PIK3CG CDH2	3.47e-05	3	119	2	17646933
Pubmed	PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.	ADGRV1 USH2A	3.47e-05	3	119	2	20440071
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRS	3.47e-05	3	119	2	31985401
Pubmed	A comparison of the bone and growth phenotype of mdx, mdx:Cmah-/- and mdx:Utrn+/- murine models with the C57BL/10 wild-type mouse.	DMD CMAHP	3.47e-05	3	119	2	31754018
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRS	3.47e-05	3	119	2	20139422
Pubmed	N-cadherin mediates the migration of MCF-10A cells undergoing bone morphogenetic protein 4-mediated epithelial mesenchymal transition.	BMP4 CDH2	3.47e-05	3	119	2	25542234
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRS	3.47e-05	3	119	2	33656439
Pubmed	Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion.	CD4 SMPD1	3.47e-05	3	119	2	17344303
Pubmed	Effects of the exogenous Nef protein on HIV-1 target cells.	FN1 CD4	3.47e-05	3	119	2	10451539
Pubmed	The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells.	NPC1 SMPD1	3.47e-05	3	119	2	37407594
Pubmed	Nr-CAM expression in the developing mouse nervous system: ventral midline structures, specific fiber tracts, and neuropilar regions.	NRCAM CNTN2	3.47e-05	3	119	2	11329126
Pubmed	PI3Kγ is a molecular switch that controls immune suppression.	CD4 PIK3CG	3.47e-05	3	119	2	27642729
Pubmed	Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity.	SP3 DMD	3.47e-05	3	119	2	15550398
Pubmed	A secreted protein promotes cleavage furrow maturation during cytokinesis.	HMCN2 HMCN1	3.47e-05	3	119	2	21215633
Pubmed	Non-USH2A mutations in USH2 patients.	ADGRV1 USH2A	3.47e-05	3	119	2	22147658
Pubmed	Sema6B, Sema6C, and Sema6D expression and function during mammalian retinal development.	SEMA6B SEMA6D	3.47e-05	3	119	2	23646199
Pubmed	F3/contactin and TAG1 play antagonistic roles in the regulation of sonic hedgehog-induced cerebellar granule neuron progenitor proliferation.	NRCAM CNTN2	3.47e-05	3	119	2	21205796
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRS	3.47e-05	3	119	2	9784606
Pubmed	A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase.	NPC1 SMPD1	3.47e-05	3	119	2	6257302
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	3.47e-05	3	119	2	25394468
Pubmed	Targeted next generation sequencing in Italian patients with Usher syndrome: phenotype-genotype correlations.	ADGRV1 USH2A	3.47e-05	3	119	2	29142287
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	HMCN2 HMCN1	3.47e-05	3	119	2	17015624
Pubmed	Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.	FN1 CDH2	3.47e-05	3	119	2	17512904
Pubmed	Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas.	CDH2 CDH4	3.47e-05	3	119	2	1406710
Pubmed	The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1.	ADGRV1 USH2A	3.47e-05	3	119	2	16434480
Pubmed	Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations.	NF2 DMD	3.47e-05	3	119	2	19687056
Pubmed	Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.	NPC1 SMPD1	3.47e-05	3	119	2	16950136
Pubmed	Stat3 loss in mesenchymal progenitors causes Job syndrome-like skeletal defects by reducing Wnt/β-catenin signaling.	TNFRSF11B PHEX ADGRE1	4.97e-05	21	119	3	34172578
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	SEMA6B SDK2 PTK7 SEMA6D SDK1	5.32e-05	117	119	5	17145500
Pubmed	β1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation.	FN1 VCAN CDH2	5.74e-05	22	119	3	38794925
Pubmed	KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.	ERBB4 FN1 SEMA6D	6.58e-05	23	119	3	28164238
Pubmed	Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.	ADGRV1 USH2A	6.93e-05	4	119	2	18463160
Pubmed	Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss.	ADGRV1 USH2A	6.93e-05	4	119	2	20502675
Pubmed	Developmental defects in mouse embryos lacking N-cadherin.	CDH2 CDH4	6.93e-05	4	119	2	9015265
Pubmed	Usher Syndrome Type II	ADGRV1 USH2A	6.93e-05	4	119	2	20301515
Pubmed	Characterization of the human tubulin tyrosine ligase-like 1 gene (TTLL1) mapping to 22q13.1.	TTLL4 TTLL1	6.93e-05	4	119	2	11054573
Pubmed	The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.	PTPRD PTPRS	6.93e-05	4	119	2	8524829
Pubmed	ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.	DMD ADGRE1	6.93e-05	4	119	2	12414501
Pubmed	Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.	CCNA2 BUB1B	6.93e-05	4	119	2	30765611
Pubmed	Analysis of interactions of the adhesion molecule TAG-1 and its domains with other immunoglobulin superfamily members.	NRCAM CNTN2	6.93e-05	4	119	2	12139915
Pubmed	Phosphoinositide 3-kinase regulates crosstalk between Trk A tyrosine kinase and p75(NTR)-dependent sphingolipid signaling pathways.	PIK3CG SMPD1	6.93e-05	4	119	2	11238738
Pubmed	Ultrastructural localization of microfibrillar fibulin-1 and fibulin-2 during heart development indicates a switch in molecular associations.	FN1 VCAN	6.93e-05	4	119	2	9676579
Pubmed	Adenylyl cyclase 6 plays a minor role in the mouse inner ear and retina.	ADGRV1 USH2A	6.93e-05	4	119	2	37127773
Pubmed	Whole chromosome aneuploidy in the brain of Bub1bH/H and Ercc1-/Δ7 mice.	BUB1B ADGRE1	6.93e-05	4	119	2	26681803
Interaction	C2CD4B interactions	ICE1 ADGRV1 SETD2 GPRASP2 ALPK2	5.48e-06	44	117	5	int:C2CD4B
Cytoband	18q11.2	NPC1 LAMA3 CDH2	2.53e-04	47	119	3	18q11.2
Cytoband	4q27	CCNA2 PDE5A	1.49e-03	22	119	2	4q27
Cytoband	20p13	HSPA12B RBCK1 CPXM1	2.42e-03	102	119	3	20p13
Cytoband	Ensembl 112 genes in cytogenetic band chr18q12	SLC14A1 ELP2 CDH2	2.56e-03	104	119	3	chr18q12
Cytoband	21q22.2	DOP1B BRWD1	3.34e-03	33	119	2	21q22.2
Cytoband	19p13.3	SEMA6B PTPRS ADGRE1 PCSK4	3.46e-03	237	119	4	19p13.3
GeneFamily	Fibronectin type III domain containing	SDK2 FN1 NRCAM INSRR FNDC3A DSCAML1 PTPRD PTPRS PTPRQ MYOM2 USH2A SDK1 CNTN2 MYBPC3	2.24e-14	160	85	14	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 NRCAM DSCAML1 OPCML PTK7 HMCN2 PTPRD HMCN1 PTPRS MYOM2 SDK1 CNTN2 ALPK2 MYBPC3	2.45e-14	161	85	14	593
GeneFamily	Immunoglobulin like domain containing	SDK2 NRCAM DSCAML1 PTK7 HMCN2 MYOM2 SDK1 CNTN2	3.48e-06	193	85	8	594
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRS PTPRQ	1.25e-04	21	85	3	813
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 USH2A	1.30e-04	4	85	2	1244
GeneFamily	CD molecules\|Type I classical cadherins	CDH2 CDH4	2.16e-04	5	85	2	1185
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYOM2 MYBPC3	6.00e-04	8	85	2	658
GeneFamily	Fibulins	HMCN2 HMCN1	6.00e-04	8	85	2	556
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	INSRR STYK1 PTK7	8.74e-04	40	85	3	321
GeneFamily	Tubulin tyrosine ligase family	TTLL4 TTLL1	1.92e-03	14	85	2	779
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA6B SEMA6D	3.93e-03	20	85	2	736
GeneFamily	WD repeat domain containing	STXBP5 WDR43 ELP2 BRWD1 WDR72	7.87e-03	262	85	5	362
Coexpression	GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	KLK11 ERBB4 ATP10A OPCML CDKAL1 PRKAB2 CA5B CDH4	2.88e-06	196	117	8	M8135
Coexpression	CHEBOTAEV_GR_TARGETS_DN	NRCAM TNFRSF11B SLC14A1 HSD17B13 STAG3 GPRASP2	2.02e-05	124	117	6	M7876
Coexpression	CHEBOTAEV_GR_TARGETS_DN	NRCAM TNFRSF11B SLC14A1 HSD17B13 STAG3 GPRASP2	2.88e-05	132	117	6	MM470
Coexpression	GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN	NPC1 MAN2B1 ATP10A PHEX CD4 PTPRS PIK3CG	3.10e-05	198	117	7	M4959
Coexpression	GSE17721_0.5H_VS_4H_CPG_BMDC_DN	RNF19B FNDC3A ATP10A DSCAML1 CD72 ADGRE1 ALPK2	3.31e-05	200	117	7	M4125
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM ADGRV1 DSCAML1 PTPRD HMCN1 PTPRQ MYOM2 DMD USH2A DNAH9 SDK1 CNTN2	8.04e-14	184	117	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM ADGRV1 DSCAML1 PTPRD HMCN1 PTPRQ MYOM2 DMD USH2A DNAH9 SDK1 CNTN2	8.04e-14	184	117	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM ADGRV1 DSCAML1 PTPRD HMCN1 PTPRQ MYOM2 DMD USH2A DNAH9 SDK1 CNTN2	8.04e-14	184	117	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 NRCAM PTK7 PHEX BMP4 PTPRD VCAN CPXM1 SDK1	3.09e-09	200	117	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	FN1 LAMA3 ATP10A TNFRSF11B HMCN2 PDE5A DMD SDK1	3.00e-08	183	117	8	818fd886e0188091310825f9145fa53328f2c979
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	ERBB4 FN1 LAMA3 ATP10A TNFRSF11B HMCN2 DMD SDK1	3.70e-08	188	117	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	PND07\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FN1 NRCAM PHEX PTPRD HMCN1 VCAN CPXM1 PDE5A	4.36e-08	192	117	8	8171a60df481195c39a7f740effcae8e4deb6ca7
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 FN1 NRCAM PTK7 PHEX BMP4 PTPRD VCAN	5.74e-08	199	117	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SDK2 FN1 NRCAM PTK7 PHEX BMP4 PTPRD VCAN	5.74e-08	199	117	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	KLK11 NRCAM MUC16 TNFRSF11B PTPRQ CPXM1 CDH2	2.89e-07	166	117	7	4d63c758d46e73311b864148c646bf081498dee7
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	KLK11 NRCAM MUC16 TNFRSF11B PTPRQ CPXM1 CDH2	2.89e-07	166	117	7	4160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8\|TCGA-Thryoid / Sample_Type by Project: Shred V9	HIVEP1 PTK7 ARAP3 DMD CA5B SDK1 SHISA6	3.14e-07	168	117	7	00646601548b0fee42ae16bfa5e93603bc7c5129
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 HMCN1 PTPRQ CD72 USH2A DNAH9 WDR72	4.13e-07	175	117	7	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KLK11 ERBB4 ADGRV1 PTPRD SEMA6D HSD17B13 ELAPOR1	5.00e-07	180	117	7	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	FN1 LAMA3 ATP10A HMCN2 PDE5A DMD SDK1	5.58e-07	183	117	7	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1\|GI_small-bowel / Manually curated celltypes from each tissue	HTR3A FBXO17 DSCAML1 DMD CDH2 SDK1 CDH17	5.79e-07	184	117	7	8e393eea7240584a3cef718bee094e2705ec1891
ToppCell	Mild_COVID-19-Epithelial-AT1/AT2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ERBB4 NRCAM AP1M2 TNFRSF11B PTK7 CDH2 WDR72	6.01e-07	185	117	7	c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SEMA6B LAMA3 MUC16 TTYH3 ADGRV1 VCAN USH2A	6.23e-07	186	117	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NRCAM FNDC3A CASZ1 MUCL1 VCAN CPXM1 SDK1	6.46e-07	187	117	7	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	6.69e-07	188	117	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	6.94e-07	189	117	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FN1 PTK7 PHEX PTPRD HMCN1 PTPRS VCAN	6.94e-07	189	117	7	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA6B FN1 LAMA3 OPCML ARAP3 HMCN2 SLC14A1	6.94e-07	189	117	7	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	FN1 LAMA3 ATP10A TNFRSF11B HMCN2 DMD SDK1	6.94e-07	189	117	7	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM PHEX BMP4 PTPRD PTPRS SDK1	6.94e-07	189	117	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ERBB4 FNDC3A MYOM2 DMD CDH2 ALPK2 MYBPC3	7.19e-07	190	117	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FN1 PTK7 PHEX PTPRD HMCN1 PTPRS VCAN	7.19e-07	190	117	7	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	7.19e-07	190	117	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 NRCAM PTK7 PHEX BMP4 PTPRD SDK1	7.19e-07	190	117	7	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	7.44e-07	191	117	7	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FN1 NRCAM OPCML PHEX PTPRD VCAN CPXM1	7.71e-07	192	117	7	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FN1 FBXO17 PHEX BMP4 SEMA6D CDH2 WDR72	7.98e-07	193	117	7	5e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SDK2 PHEX HMCN1 PTPRS PDE5A CDH4 SDK1	7.98e-07	193	117	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	SDK2 FN1 PHEX PTPRD HMCN1 PTPRS SDK1	7.98e-07	193	117	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	8.26e-07	194	117	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	8.55e-07	195	117	7	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ERBB4 CASZ1 MYOM2 DMD CDH2 ALPK2 MYBPC3	8.55e-07	195	117	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FN1 NRCAM PTPRD HMCN1 VCAN CPXM1 PDE5A	8.85e-07	196	117	7	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FN1 NRCAM OPCML PHEX PTPRD VCAN CPXM1	8.85e-07	196	117	7	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FN1 NRCAM OPCML PHEX PTPRD VCAN CPXM1	8.85e-07	196	117	7	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	FN1 NRCAM PTPRD HMCN1 PTPRS VCAN SDK1	9.47e-07	198	117	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 TNFRSF11B PTK7 PHEX PTPRD VCAN SDK1	9.80e-07	199	117	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	FN1 NRCAM PTK7 PHEX BMP4 PTPRD VCAN	1.01e-06	200	117	7	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FN1 PTK7 PHEX BMP4 PTPRD PEBP1 VCAN	1.01e-06	200	117	7	0ed49c2177b58269ff7653db6be7d68633a5d34a
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FN1 FBXO17 PHEX BMP4 PTPRD SEMA6D CDH2	1.01e-06	200	117	7	3c898e81444b001835c3f1bbc68183078701b135
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SDK2 FN1 PTK7 PHEX BMP4 PTPRD VCAN	1.01e-06	200	117	7	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FN1 FBXO17 PHEX BMP4 PTPRD SEMA6D CDH2	1.01e-06	200	117	7	3eca8ffeb41b664fbdbbd70b375c5d953503ab29
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	FN1 NRCAM PTK7 PHEX BMP4 PTPRD VCAN	1.01e-06	200	117	7	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SDK2 FN1 PTK7 PHEX BMP4 PTPRD VCAN	1.01e-06	200	117	7	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FN1 NRCAM PTK7 PHEX BMP4 PTPRD VCAN	1.01e-06	200	117	7	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SDK2 ATP10A BMP4 SLC7A3 VCAN SDK1	4.16e-06	160	117	6	6215ac6123a295f3c2f033786602a57b2e2e1177
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 DSCAML1 HMCN1 PTPRQ USH2A DNAH9	4.16e-06	160	117	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA6B ERBB4 FN1 SLC4A1 PHEX MYBPC3	4.16e-06	160	117	6	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA6B ERBB4 FN1 SLC4A1 PHEX MYBPC3	4.16e-06	160	117	6	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 DSCAML1 HMCN1 PTPRQ USH2A DNAH9	4.16e-06	160	117	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FN1 PHEX PTPRD VCAN HSD17B13 CPXM1	4.31e-06	161	117	6	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	Ciliated_cells-A-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	KLK11 SLC7A3 HSD17B13 CDH2 DNAH9 SHISA6	4.63e-06	163	117	6	43194c6127df1ce3d29242f719645de3c11fd7c0
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAML1 TNFRSF11B CDH2 SDK1 ALPK2 WDR72	5.50e-06	168	117	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ERBB4 HTR3A PDE5A SDK1 SHISA6	5.52e-06	96	117	5	78f19fee755061b4144b1beebb60f4e8bc4dbf0d
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SDK2 NRCAM TNFRSF11B SLC14A1 CDH2 WDR72	5.89e-06	170	117	6	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIVEP1 MAN2B1 PHEX CD4 PTPRS PIK3CG	6.09e-06	171	117	6	4fd2c7977c512c51507f055fc74b111c0228ed8b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPC1 ATP10A PHEX CD4 PTPRS PIK3CG	6.09e-06	171	117	6	af1c93eb75f45c042ea475d93db56e4da207e31f
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A ZNF318 CCNA2 BUB1B CD72 STAG3	6.51e-06	173	117	6	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 NRCAM ADGRV1 DSCAML1 SEMA6D SHISA6	6.95e-06	175	117	6	e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SDK2 HIVEP1 PHEX PTPRS PIK3CG KLHDC4	6.95e-06	175	117	6	37c2d4e0b6e9a3171931797ce9a54f3347288e57
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 HMCN1 PTPRQ CD72 USH2A DNAH9	7.18e-06	176	117	6	c6484334187f64cd00cd35e77d8ae436556b4260
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	MYO18A ATP10A PTK7 PHEX CD4 PTPRS	7.18e-06	176	117	6	d6e660df92a3d7dd5732171ee623763faf108476
ToppCell	Control-Myeloid-pDC\|Control / Disease state, Lineage and Cell class	SDK2 HIVEP1 PHEX PTPRS PIK3CG KLHDC4	7.42e-06	177	117	6	3940663bb5b45b2ca9f772550380a516c53e410b
ToppCell	PBMC-Mild-cDC_11\|Mild / Compartment, Disease Groups and Clusters	HTR3A RGS11 FBXO17 TOMM34 DMD SDK1	7.42e-06	177	117	6	974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	FN1 RGS11 PTPRD HMCN1 PTPRS PTPRQ	7.42e-06	177	117	6	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAN2B1 HTR3A PHEX CD4 PTPRS PIK3CG	7.42e-06	177	117	6	8887ff6341eb070bdaa890cc2cd7745f0cf1b0af
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAN2B1 HTR3A PHEX CD4 PTPRS PIK3CG	7.42e-06	177	117	6	507f06d31ab773099c9431b6f433899dc97b5566
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	FN1 RGS11 PTPRD HMCN1 PTPRS PTPRQ	7.42e-06	177	117	6	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	Control-Myeloid-pDC\|World / Disease state, Lineage and Cell class	SDK2 HIVEP1 PHEX PTPRS PIK3CG KLHDC4	7.66e-06	178	117	6	20ef63d925e67ddd5955832312ca8574a6f838a4
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 DSCAML1 CDH2 SDK1 ALPK2 WDR72	7.66e-06	178	117	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM RGS11 PTPRD SEMA6D PDE5A CCL16	7.91e-06	179	117	6	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SDK2 RGS11 BMP4 CPXM1 DMD SDK1	7.91e-06	179	117	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBXO17 DSCAML1 PTPRD CDH2 ALPK2 WDR72	8.17e-06	180	117	6	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 HTR3A LAMA3 SEMA6D VCAN SHISA6	8.43e-06	181	117	6	6c55985e464cb0f5fb3362e9fd90351b671950f7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATP10A DSCAML1 TNFRSF11B PTPRD CDH2 ALPK2	8.70e-06	182	117	6	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NRCAM ATP10A BMP4 MUCL1 CDH2 SHISA6	8.70e-06	182	117	6	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRCAM FBXO17 DSCAML1 PTPRD ALPK2 WDR72	8.97e-06	183	117	6	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ATP10A CASZ1 PTPRD PTPRQ DNAH9 SHISA6	8.97e-06	183	117	6	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ATP10A CASZ1 PTPRD PTPRQ DNAH9 SHISA6	8.97e-06	183	117	6	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC3A PTPRD SEMA6D DMD CA5B ALPK2	8.97e-06	183	117	6	ffb1bbbccb34d1a7e99872611f497450039d5019
ToppCell	3'_v3-GI_small-bowel-Myeloid_Dendritic\|GI_small-bowel / Manually curated celltypes from each tissue	HTR3A FBXO17 DSCAML1 DMD CDH2 CDH17	8.97e-06	183	117	6	6109199cf25b28831193a5ed7925b5bf38c6eb43
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	HIVEP1 ATP10A DSCAML1 PTPRD VCAN SDK1	9.26e-06	184	117	6	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 SDK2 HTR3A SEMA6D CDH4 SHISA6	9.55e-06	185	117	6	79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	KLK11 ERBB4 ADGRV1 PTPRD ELAPOR1 SDK1	9.55e-06	185	117	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADGRV1 OPCML VCAN HSD17B13 MYOM2 CMAHP	1.01e-05	187	117	6	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	FN1 TNFRSF11B HMCN1 PTPRS PDE5A SDK1	1.01e-05	187	117	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	COVID-19-kidney-Mito-rich_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	TTYH3 DSCAML1 PTPRD CDH2 ALPK2 WDR72	1.01e-05	187	117	6	738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 CDH2 ALPK2 MYBPC3	1.01e-05	187	117	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	FN1 NRCAM PTPRD PTPRS VCAN PDE5A	1.05e-05	188	117	6	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	FN1 NRCAM PHEX PTPRD VCAN CPXM1	1.05e-05	188	117	6	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OPCML TNFRSF11B SLC7A3 PTPRS VCAN CPXM1	1.05e-05	188	117	6	006db2c2c44971ca9241c582bc89f258c785f5ed
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OPCML TNFRSF11B SLC7A3 PTPRS VCAN CPXM1	1.05e-05	188	117	6	d0e6fb4a3b3d79d3512b5500062ea285495ae526
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	ERBB4 CASZ1 MYOM2 CDH2 ALPK2 MYBPC3	1.08e-05	189	117	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 RGS11 ADGRV1 TNFRSF11B PTK7 SEMA6D	1.08e-05	189	117	6	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPC1 ERBB4 PLEKHG2 ADGRV1 DSCAML1 ALPK2	1.08e-05	189	117	6	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
Computational	Adhesion molecules.	FN1 LAMA3 PTK7 PTPRS ADGRE1 CDH2 CDH17	3.80e-05	141	71	7	MODULE_122
Computational	Genes in the cancer module 27.	ERBB4 HTR3A OPCML TNFRSF11B PTK7 CD4 PTPRS CD72 ADGRE1 GP1BA	1.04e-04	355	71	10	MODULE_27
Drug	AC1NS1NG	NPC1 ERBB4 FN1 FNDC3A ADGRV1 CD4 SMPD1 CTH	9.39e-07	147	117	8	CID005327099
Drug	AC1NRATE	MAN2B1 FN1 FNDC3A CD4 SLC14A1 DMD	4.43e-06	83	117	6	CID005288086
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A	CRYBG2 ATP10A TNFRSF11B PTK7 C22orf31 VCAN TTLL4 TTLL1	8.00e-06	196	117	8	6416_UP
Drug	R-Te	NPC1 FN1 PTK7 CD4 DNAH9	1.11e-05	57	117	5	CID000068913
Drug	hexahydroindole	SP3 FN1	2.62e-05	2	117	2	CID000579465
Drug	MDMO-PPV	SLC4A1 CCL16	2.62e-05	2	117	2	CID005225511
Drug	4,6-dinitrohexanoate	DECR1 SMPD1	2.62e-05	2	117	2	CID009543366
Drug	2,4-dinitrocyclohexanone	DECR1 SMPD1	2.62e-05	2	117	2	CID009543365
Drug	p-mentha-1,8-dien-3-one	DECR1 SPEN	2.62e-05	2	117	2	CID000079036
Drug	Ikvav	FN1 LAMA3 FNDC3A DMD	4.27e-05	38	117	4	CID000131343
Drug	AC1L1B8E	FN1 FNDC3A SDK1	5.75e-05	15	117	3	CID000001327
Drug	Delcorine; Up 200; 8.4uM; PC3; HT_HG-U133A	HTR3A OPCML SEMA6D NF2 VCAN CCL16 DOP1B	6.17e-05	192	117	7	3715_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CASZ1 CDKAL1 TNFRSF11B TTBK2 TTLL1 SPEN STAG3	6.37e-05	193	117	7	2209_DN
Drug	Econazole nitrate [24169-02-6]; Up 200; 9uM; HL60; HT_HG-U133A	ATP10A CDKAL1 PHEX SMPD1 CTH KLHDC4 CDH2	6.80e-05	195	117	7	2396_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	FN1 RNF19B DESI2 PHEX PTPRS TTLL4 DOP1B	7.02e-05	196	117	7	6402_DN
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	TSNAXIP1 RNF19B FNDC3A DESI2 NF2 SLC14A1 CA5B	7.02e-05	196	117	7	7310_UP
Drug	poly(methylmethacrylate	FN1 CCL16 GP1BA	7.05e-05	16	117	3	CID000522750
Drug	Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A	FNDC3A CDKAL1 RBCK1 NF2 VCAN SMPD1 CA5B	7.25e-05	197	117	7	7148_UP
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; PC3; HT_HG-U133A	RNF19B STYK1 SETD2 VCAN TTLL4 DOP1B BRWD1	7.25e-05	197	117	7	5874_DN
Drug	Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A	CRYBG2 FN1 AP1M2 YTHDC2 ATP10A TTLL4 CDH2	7.49e-05	198	117	7	2492_UP
Drug	Tridihexethyl chloride; Down 200; 11.4uM; PC3; HT_HG-U133A	STYK1 PHEX NF2 VCAN CA5B STAG3 BRWD1	7.49e-05	198	117	7	5067_DN
Drug	Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	RNF19B ZNF318 DESI2 CASZ1 TNFRSF11B NF2 TTLL4	7.49e-05	198	117	7	7363_DN
Drug	Merbromin [129-16-8]; Up 200; 5uM; PC3; HT_HG-U133A	TSNAXIP1 AP1M2 ATP10A CDKAL1 CD4 SEMA6D VCAN	7.49e-05	198	117	7	7398_UP
Drug	pyrrolidinium	MAN2B1 SLC4A1 DECR1 PHEX DMD	7.77e-05	85	117	5	CID000031268
Drug	phenylpyrrolidine	SP3 DECR1	7.83e-05	3	117	2	CID000077726
Drug	Arg-Phe-Asp-Ser	FN1 CD4	7.83e-05	3	117	2	CID005236782
Drug	VSVs	TNFRSF11B CD4	7.83e-05	3	117	2	CID009549796
Drug	U-320	FN1 FNDC3A	7.83e-05	3	117	2	CID000077162
Drug	piperitenone	SLC4A1 DECR1	7.83e-05	3	117	2	CID000381152
Drug	NSC-381858	DECR1 VCAN	7.83e-05	3	117	2	CID000343067
Drug	Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A	FN1 ATP10A CDKAL1 BMP4 NF2 TTLL4 STAG3	7.97e-05	200	117	7	6264_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RNF19B FNDC3A YTHDC2 CDKAL1 TTBK2 BMP4 NF2	7.97e-05	200	117	7	5395_DN
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A	CASZ1 NF2 PTPRS ADGRE1 CA5B BRWD1 MYBPC3	7.97e-05	200	117	7	2141_UP
Drug	1zd2	FN1 LAMA3 FNDC3A VCAN	8.39e-05	45	117	4	CID004149241
Drug	orthovanadate	ERBB4 SLC4A1 DECR1 SETD2 PTPRD SLC14A1 PTPRS ALG5 PDE5A DNAH9	8.45e-05	435	117	10	CID000061672
Drug	Methamphetamine	HTR3A FN1 ADCK5 MYO18A ICE1 PLEKHG2 HSPA12B CCNA2 ARAP3 PTPRS PEBP1 TTLL4 BUB1B DMD CA5B USH2A CNTN2 BRWD1 MYBPC3	9.35e-05	1401	117	19	ctd:D008694
Disease	Embryonal Rhabdomyosarcoma	SETD2 BUB1B DMD	3.35e-06	8	117	3	C0206656
Disease	Malignant neoplasm of breast	ERBB4 FN1 NRCAM ZNF318 BMP4 SETD2 ARAP3 PTPRD NF2 ELAPOR1 TIMELESS DMD SPEN CDH2 DNAH9	2.33e-05	1074	117	15	C0006142
Disease	Sphingomyelin/cholesterol lipidosis	NPC1 SMPD1	4.66e-05	3	117	2	cv:C0028064
Disease	brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement	ATP10A CDKAL1 PTPRD	8.86e-05	22	117	3	EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798
Disease	malignant pleural mesothelioma (is_implicated_in)	SETD2 NF2	9.30e-05	4	117	2	DOID:7474 (is_implicated_in)
Disease	Niemann-Pick disease (implicated_via_orthology)	NPC1 SMPD1	9.30e-05	4	117	2	DOID:14504 (implicated_via_orthology)
Disease	TEMPS-A questionnaire	ERBB4 CEP295 SHISA6	1.31e-04	25	117	3	EFO_0004783
Disease	Distal Renal Tubular Acidosis	SLC4A1 WDR72	1.55e-04	5	117	2	C1704380
Disease	Duchenne and Becker Muscular Dystrophy	CD4 DMD	1.55e-04	5	117	2	C3542021
Disease	Becker Muscular Dystrophy	CD4 DMD	1.55e-04	5	117	2	C0917713
Disease	behavioural disinhibition measurement	FN1 CDKAL1 SEMA6D DNAH9	2.30e-04	75	117	4	EFO_0006946
Disease	Muscular Dystrophy, Duchenne	CD4 DMD	2.31e-04	6	117	2	C0013264
Disease	Cardiomegaly	RBCK1 PIK3CG DMD MYBPC3	3.24e-04	82	117	4	C0018800
Disease	post-traumatic stress disorder symptom measurement	OPCML PTPRD PIK3CG CDH4	3.24e-04	82	117	4	EFO_0008535
Disease	Cardiac Hypertrophy	RBCK1 PIK3CG DMD MYBPC3	3.24e-04	82	117	4	C1383860
Disease	refractive error	DSCAML1 OPCML BMP4 PDE5A CDH2 SHISA6 MYBPC3	3.31e-04	326	117	7	MONDO_0004892
Disease	blood urea nitrogen measurement	ZNF318 ADGRV1 CASZ1 BMP4 PIK3CG BUB1B DMD WDR72	4.53e-04	452	117	8	EFO_0004741
Disease	isovalerate measurement	CD4 USH2A	5.51e-04	9	117	2	EFO_0021051
Disease	Situs ambiguous	PKD1L1 DNAH9	5.51e-04	9	117	2	C1167664
Disease	complement factor H-related protein 3 measurement	ADGRV1 DMD USH2A CDH4 SDK1	5.80e-04	169	117	5	EFO_0600056
Disease	carbohydrate measurement	MYO18A OPCML TNFRSF11B	8.14e-04	46	117	3	EFO_0004998
Disease	urate measurement, bone density	ERBB4 CASZ1 CDKAL1 RBCK1 PTPRD TTLL1 USH2A DNAH9 CDH4	8.23e-04	619	117	9	EFO_0003923, EFO_0004531
Disease	gastrointestinal stromal tumor (is_implicated_in)	SETD2 NF2	8.38e-04	11	117	2	DOID:9253 (is_implicated_in)
Disease	interleukin-6 measurement, response to stimulus	MUC16 CMAHP	8.38e-04	11	117	2	EFO_0004810, GO_0050896
Disease	Situs Inversus	PKD1L1 DNAH9	8.38e-04	11	117	2	C0037221
Disease	disease progression measurement, Crohn's disease	OPCML PTPRD SDK1	8.68e-04	47	117	3	EFO_0000384, EFO_0008336
Disease	Hepatic fibrosis	ERBB4 SDK2 SDK1	9.80e-04	49	117	3	HP_0001395
Disease	conotruncal heart malformations	HIVEP1 ADGRV1 PTPRD SHISA6	1.12e-03	114	117	4	MONDO_0016581
Disease	cystatin C measurement	ERBB4 FNDC3A ADGRV1 PDE5A CTH MYBPC3 WDR72	1.14e-03	402	117	7	EFO_0004617
Disease	waist-hip ratio	NPC1 ERBB4 FN1 YTHDC2 ZNF318 OPCML CDKAL1 PTK7 PTPRD PTPRS PDE5A CNTN2 SHISA6	1.17e-03	1226	117	13	EFO_0004343
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP1 BMP4	1.18e-03	13	117	2	DOID:0050787 (implicated_via_orthology)
Disease	iron deficiency anemia (biomarker_via_orthology)	FN1 SLC4A1	1.18e-03	13	117	2	DOID:11758 (biomarker_via_orthology)
Disease	household income	NPC1 ERBB4 ARAP3 SEMA6D CDH2 CDH4	1.37e-03	304	117	6	EFO_0009695
Disease	lysophosphatidylcholine 16:1 measurement	OPCML CDKAL1	1.38e-03	14	117	2	EFO_0010358
Disease	malignant pleural mesothelioma (is_marker_for)	SETD2 NF2	1.38e-03	14	117	2	DOID:7474 (is_marker_for)
Disease	colorectal cancer (is_implicated_in)	ERBB4 SETD2 NF2 BUB1B	1.40e-03	121	117	4	DOID:9256 (is_implicated_in)
Disease	Down syndrome (implicated_via_orthology)	DSCAML1 DOP1B	1.58e-03	15	117	2	DOID:14250 (implicated_via_orthology)
Disease	Opioid use measurement	PTPRD MYOM2	1.58e-03	15	117	2	EFO_0009937
Disease	Situs ambiguus	PKD1L1 DNAH9	1.58e-03	15	117	2	C0266642
Disease	response to olanzapine	HIVEP1 ADGRV1	1.58e-03	15	117	2	GO_0097333
Disease	cognitive function measurement	ERBB4 HIVEP1 YTHDC2 DESI2 OPCML ARAP3 PTPRD SEMA6D USH2A CDH2 CDH4 SDK1 CDH17 MYBPC3	1.65e-03	1434	117	14	EFO_0008354
Disease	developmental dysplasia of the hip	OPCML SHISA6	1.80e-03	16	117	2	EFO_1000648
Disease	Colorectal Carcinoma	FN1 NRCAM DSCAML1 BMP4 ARAP3 PTPRD PTPRS BUB1B DMD	1.96e-03	702	117	9	C0009402
Disease	non-high density lipoprotein cholesterol measurement	NPC1 HIVEP1 FN1 AKNA CDKAL1 RBCK1 CMAHP BRWD1 WDR72	2.18e-03	713	117	9	EFO_0005689
Disease	monocyte count	CRYBG2 HIVEP1 FN1 STXBP5 ADGRV1 CASZ1 CDKAL1 SETD2 PIK3CG VCAN PDE5A CMAHP MYBPC3	2.24e-03	1320	117	13	EFO_0005091
Disease	glucose homeostasis measurement, acute insulin response measurement	SDK2 CDKAL1	2.29e-03	18	117	2	EFO_0006831, EFO_0006896
Disease	nephrotic syndrome (is_marker_for)	TNFRSF11B GP1BA	2.29e-03	18	117	2	DOID:1184 (is_marker_for)
Disease	disease free survival	ICE1 CCDC168	2.29e-03	18	117	2	EFO_0000409
Disease	age at menarche	ERBB4 FNDC3A DSCAML1 CDKAL1 PTK7 PTPRD SEMA6D BRWD1	2.58e-03	594	117	8	EFO_0004703
Disease	pulse pressure measurement, alcohol drinking	ZNF318 CASZ1 CDH17	2.74e-03	70	117	3	EFO_0004329, EFO_0005763
Disease	unipolar depression	ERBB4 YTHDC2 OPCML CDKAL1 ARAP3 PTPRD SEMA6D VCAN ELP2 DMD CDH4 SDK1	3.05e-03	1206	117	12	EFO_0003761
Disease	epilepsy (biomarker_via_orthology)	BMP4 NF2	3.12e-03	21	117	2	DOID:1826 (biomarker_via_orthology)
Disease	fetal hemoglobin measurement	YTHDC2 PHEX	3.12e-03	21	117	2	EFO_0004576
Disease	autism spectrum disorder (implicated_via_orthology)	NRCAM DSCAML1 ELP2 GPRASP2	3.20e-03	152	117	4	DOID:0060041 (implicated_via_orthology)
Disease	otitis media (implicated_via_orthology)	PHEX NF2	3.42e-03	22	117	2	DOID:10754 (implicated_via_orthology)
Disease	myocardial infarction (biomarker_via_orthology)	FN1 CCNA2 PEBP1 VCAN	3.84e-03	160	117	4	DOID:5844 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LTVIKVSSQPVPWDF	BUB1B	791	O60566
IVRNPWPSNLTLVST	ERBB4	166	Q15303
TPPLSESVTWIIKKQ	CA5B	236	Q9Y2D0
STTREWTVKPENPLT	ARAP3	1426	Q8WWN8
KSRVPPTVTNAVSWR	AP1M2	146	Q9Y6Q5
IITSASRSQPKVPEW	CCL16	16	O15467
TNFPQTIEPAKLWSR	VCAN	2086	P13611
VLWVVKSTPASLALP	SLC4A1	846	P02730
WNRIPTASSPSTLII	ADGRG4	2156	Q8IZF6
IVSFPWEKPTTLTAN	ALPK2	981	Q86TB3
QLSWPAPSTKTEERV	CASZ1	251	Q86V15
DIFSSWNISLPTVPK	SMPD1	171	P17405
LPSIWDSPTKQLSVV	ALG5	56	Q9Y673
PVRDWRKPTTVSIDV	HTR3A	51	P46098
PSANVKLGWPRTVTV	ADGRV1	121	Q8WXG9
KLGWPRTVTVTILSN	ADGRV1	126	Q8WXG9
TKLVWIETPTNPTQK	CTH	151	P32929
PNATVAPETRAVIKW	CPXM1	471	Q96SM3
KPTQQARPTVIRWSE	PRKAB2	71	O43741
PATTSSWEVVRNPLI	C22orf31	56	O95567
SSPTPLWRKVLSTAV	ADCK5	41	Q3MIX3
KSEQPTASWRAVTSP	CD72	66	P21854
TTTAENWLKIQPTTP	DMD	846	P11532
TKNPSTRLWPVLETD	HSD17B13	226	Q7Z5P4
DVSPAVLRWTREKQP	BMP4	216	P12644
PKEWLTPAALQSSVS	DESI2	146	Q9BSY9
GRTVKTSVPLSQPSW	ATP10A	1341	O60312
LQVLNPETRTWTTPE	RABEPK	116	Q7Z6M1
APTVAAPTKLRVERW	RGS11	286	O94810
TETPWDTRYIPVKIT	MUC16	176	Q8WXI7
ISPEIRSTVRNSPWK	MUC16	3216	Q8WXI7
LQDTPVASPRSVKVW	LAMA3	2956	Q16787
NIVVRPSRSPLWTKE	NRCAM	136	Q92823
VPAPTITWTKETNAL	HMCN2	1001	Q8NDA2
TSGVPTPQVEWTKDR	HMCN2	1461	Q8NDA2
KPEVSPTQDIRLWVS	RBCK1	46	Q9BYM8
SSRKNSWEPKPITVP	DOP1B	676	Q9Y3R5
DPTSSWRSLIPVIKV	KIAA1109	191	Q2LD37
TTAFSVWTKVPKPVL	ELAPOR1	246	Q6UXG2
VKRSVVVPTDPWFSK	PCSK4	111	Q6UW60
STTARKDIPVLPKWV	MUCL1	66	Q96DR8
KVQPIPELSELSRSW	MYO18A	306	Q92614
SAITKPWPIQQRIAE	PDE5A	766	O76074
LTPTQVKNRPTSISW	PEBP1	41	P30086
PVSITWAVRPLTLSS	KLK11	151	Q9UBX7
QSPSLPEKDTVRWVL	HSPA12B	191	Q96MM6
WRIPFDPSLKEVTVS	HMCN1	236	Q96RW7
ITWAKETQLISPFSP	HMCN1	1111	Q96RW7
TPKISFPWNEIRNIS	NF2	251	P35240
ESTQVRITWKKPRQP	PTPRQ	451	Q9UMZ3
ITLSWSPPRQESIIK	PTPRS	541	Q13332
VRVTTNPVDLWSAPS	NPC1	371	O15118
KWSIDPRVIILVNTP	OPCML	81	Q14982
VVKFSASPDPVLQWT	FBXO17	211	Q96EF6
SPTERLSPNAWKTIT	DECR1	151	Q16698
RNRPVKPSIWISSQI	ICE1	1511	Q9Y2F5
TSLRIFKWVPVVDPQ	BCL7C	41	Q8WUZ0
QNWLVEVPTVSPISR	ERVK-7	66	P61567
VAVISWSEPPRSTLN	DSCAML1	1106	Q8TD84
STVLVRWTPPRAQIT	FN1	1011	P02751
SDSTIPGIQKIWIRT	CDKAL1	56	Q5VV42
DIQARTVVLTWSPPS	FNDC3A	276	Q9Y2H6
VSATLTWRQRPPTQE	CRYBG2	16	Q8N1P7
LPFVPAAVRKNWTIT	CDH4	651	P55283
ESNIKVLPTWSTPVQ	CD4	381	P01730
KVLSFTIPQPRSAEW	AKNA	496	Q7Z591
SSLSIKWDPVVPFRN	CNTN2	926	Q02246
WITDTTLRKSPFVPQ	BRWD1	946	Q9NSI6
QNWLVEVPTVSPISR	ERVK-21	176	P61565
QESTKEQTTFPPRWT	GP1BA	346	P07359
EQVWRASTSLKPPTA	MAN2B1	236	O00754
ITIPISPWKVTSINK	INSRR	721	P14616
NTRKDTWTKVDIPSP	KLHDC4	101	Q8TBB5
PPVSSWIEKREIQTE	DNAH9	2296	Q9NYC9
NTVNPREWTPEIVIS	ELP2	371	Q6IA86
PADSLEVIPKTIRWT	CCDC168	7021	Q8NDH2
TVTGQSWPESLIRKT	CCNA2	366	P20248
STDPHPIKITQVRWN	CDH17	251	Q12864
SVISVPSWKSERPTA	CEP295	626	Q9C0D2
TTSSVLIQWQPPRDE	SDK1	1591	Q7Z5N4
VVWARTRITKPPQDQ	SDK2	491	Q58EX2
EVRTTSVRLIWQPPA	SDK2	1311	Q58EX2
TSVLIRWQPPAEDKI	SDK2	1516	Q58EX2
VARPTQTSSQRVPLW	PKD1L1	221	Q8TDX9
LPLSPVTIKRNWTIT	CDH2	641	P19022
VIWRQPQSSTPLHFK	SLC7A3	526	Q8WY07
TSVKVSWRSPVPNKQ	PTPRD	726	P23468
TSSQWQSPPVVVILK	ORC3	206	Q9UBD5
PRLSSATPTSLQVVW	USH2A	2441	O75445
KPWDISLAQPESIRS	RNF19B	651	Q6ZMZ0
SRPQTWDEVTVEFKP	GPRASP2	486	Q96D09
QSPVWVQTPSTKVVS	SHISA6	146	Q6ZSJ9
WVSRVESVPKVPIFL	SPATA31E1	881	Q6ZUB1
VDWAQKLPTVPITLT	OCSTAMP	331	Q9BR26
LTIWNVRSPAKPVQT	STXBP5	261	Q5T5C0
SFWKPSANITPAVRT	ADGRE1	416	Q14246
KNSDVITWTPRPGAT	CMAHP	286	Q9Y471
QRRTSPKPFTEEVLW	PIK3CG	396	P48736
AISSTQTIPLKWLAP	STYK1	281	Q6J9G0
QETFWRIPAKLSPTQ	TIMELESS	1076	Q9UNS1
SIPLVPVSAQKRWNS	TOMM34	146	Q15785
RFREQKSPESIWTPV	SEMA6B	351	Q9H3T3
VPTKFTPNWLSVLVD	TNFRSF11B	211	O00300
HQSPPTKVTEWITRQ	SPEN	2491	Q96T58
PTLTSTAVKSRQPLW	STAG3	1106	Q9UJ98
PNRWEVLSATPTTIK	SP3	106	Q02447
SQSRKSKIPRPVSWV	TTBK2	1046	Q6IQ55
SKIPRPVSWVNTDQV	TTBK2	1051	Q6IQ55
PREIPVTATWTLQDN	WDR72	366	Q3MJ13
LRKAVPKTEWFTNPT	PHEX	521	P78562
KLVIPITTAPNISWS	SLC14A1	201	Q13336
KWDSAIPVTTIAQPT	SAP30BP	256	Q9UHR5
LPIIQRWSQTKTAVP	SETD2	1821	Q9BYW2
RWSQTKTAVPPLSEG	SETD2	1826	Q9BYW2
PSKPWSQVDEATIRA	YTHDC2	1141	Q9H6S0
VLTDIWVQALPTSPK	PLEKHG2	1151	Q9H7P9
QEIQRTSTPRPDWTK	TSNAXIP1	311	Q2TAA8
ASIPEITPKVIDTWR	SEMA6D	601	Q8NFY4
ESSSRQKWIVKPPAS	TTLL4	711	Q14679
AELLRTVPWEQPATK	TTYH3	326	Q9C0H2
ITVATVPSWLKKPQD	PTK7	406	Q13308
WMPVVTTSTQTKIRP	ZNF318	1336	Q5VUA4
SWPQRSETLSKLPTE	HIVEP1	1261	P15822
VLVRSTTPKSVAIWG	TYSND1	381	Q2T9J0
KPWLIEVNASPSLTS	TTLL1	321	O95922
WAPKVETAITKVRTP	WDR43	381	Q15061
RDYVIVTWKPPNTTT	MYOM2	396	P54296
VSDTTVSLKWRPPER	MYBPC3	881	Q14896